Briefcase:
0 items
Toggle navigation
About
Overview
Our Team
Board of Directors
Business Collaborations
Media Center
News
Events
Press Releases
Researchers Area
Technology Transfer Process
Yissum Staff
Success Stories
Blockbuster Products
Selected Companies
Contact Us
Join Us
Home
 > 
About
 > 
Overview
Overview
Overview
Yissum is the technology transfer company of The Hebrew University of Jerusalem. Founded in 1964, it is the 3rd company of its kind ever created, and has a rich tradition of innovation and commercialization. Through our efforts to identify and create breakthrough scientific research at Hebrew University, we aspire to advance commercial solutions to the most pressing global challenges facing humanity.

Some of our well-known spin-off companies include Mobileye, Orcam, Collplant, Qlight, and Briefcam. Yissum’s business partners span the globe and include companies such as Novartis, Johnson & Johnson, Merck, Intel, Google, Boston Scientific, ICL and many more.

Since its inception, Yissum has registered 10,000+ patents covering 2,800+ inventions; licensed 900 technologies and produced 130+ spin-off companies.
Mission & Core Values
Yissum serves as a bridge between cutting-edge academic research and a global community of entrepreneurs, investors, and industry organizations. Yissum’s expertise in innovation, collaboration, and operational excellence supports the commercialization of Hebrew University’s transformational and translational discoveries.
Long-term industry-university collaborations through sponsored research, licensing options and master collaborations.
Start-up creation and support
Enterprise directed research
Leverage of government research funds
Education and training within and outside the university
Nurturing the Early Stages
Yissum believes in nurturing the next generation of entrepreneurs and ideas in their earliest stages. Through our various sponsorship and participation in vehicles dedicated to IDEATION, we support the development of early stage research while providing access to top level education and training, including guidance and feedback from experienced mentors.
HUstart,
 The Hebrew University Entrepreneurship Center, is a partnership between Yissum, the Hebrew University Faculty of Science, and the University Daniel and Raphael Recanti Jerusalem School of Business Administration. HUstart provides mentorship and support to Hebrew university students, alumni, faculty members and staff to develop and launch start up ideas. HUstart guides aspiring entrepreneurs in the basics of translating innovation into commercial ideas. For advanced entrepreneurial teams, HUstart mentors product launch, funding and growth issues. 
HUGROW
, an acceleration track of HUstart, supports the development of groundbreaking early stage research at the Robert H. Smith Faculty of Agriculture, Food, and Environment into valuable technological innovations with significant commercial potential. HUGROW prepares entrepreneurs with the necessary material to seek investments for their early stage innovations. 
Labs/02
 is Jerusalem based value-added incubator committed to investing in early stage start-ups in the AI, computer vision, deep learning, autonomic transportation and smart city sectors. It is backed by OurCrowd, Motorola Solutions, Reliance Industries, Israel Innovation Authority, and Yissum.
BioDesign
,The Hebrew University medical innovation accelerator is a partnership between Yissum, the Grass Center for Bioengineering, the Jerusalem School of Business Administration and the Hadassah Medical Center. The program creates multidisciplinary groups of medical, engineering and business fellows, providing clinical immersion, market analysis, intellectual property support, prototyping and business plan backing with the intent of guiding the groups to bring medical innovation to the market. BioDesign has launched 7 spinoffs since its inception in 2013, raising over $3 million in investment. 
Yissum Funds
Integra Holdings

Yissum founded Integra Holdings in 2012 – a unique holding company that exclusively focuses on a selection of Yissum biotech technologies including therapeutics, medical devices and diagnostics with proprietary solutions and a competitive advantage in their respective fields. Integra Holdings' portfolio is comprised of companies operating in the fields of cancer therapy, Alzheimer's disease, infectious diseases, inflammatory diseases and bipolar disorder.
Agrinnovation

Yissum founded Agrinnovation in 2015, as an investment partnership focused on nurturing agricultural inventions originating from The Hebrew University's Robert H. Smith Faculty of Agriculture Food and Environment. The partnership focuses on technologies relating to plant breeding and genetics, environmental technologies, plant protection, animal sciences, as well as veterinary and food technologies.
NanoTechFund

Yissum will be launching the NanoTechFund in 2018 to serve as an investment vehicle for Hebrew University technologies that are focused on advanced materials and nanotechnology. The fund will consider technologies related to integrated solutions using performance materials such as 3D printing, quantum materials, and solar cells.
HUnicorns™
Yissum’s HUnicorns™ are a carefully selected small group of Hebrew University spinouts built on transformational scientific breakthroughs which address global problems in remarkably innovative ways – offering solutions that will fundamentally change our tomorrows.   
About
Business Collaboration
Our Team
Directors
Disclaimer
Success Stories
Blockbuster Products
Selected Companies
Media Center
News
Events
Press Releases
Researchers Area
Yissum staff
Join Us
Becoming a member of Yissum entitles you to receive regular updates on projects according to your areas of interest.
Join Us
Contact
Address
:
Phone
:
Fax
:
Email: